|
On (b)(6) 2016, the patient was treated for an abdominal aortic aneurysm.The physician implanted a gore® excluder® aaa endoprosthesis featuring c3® delivery system and a gore® excluder® aaa endoprosthesis.The procedure was successful and the patient tolerated the procedure.On (b)(6) 2021, the patient underwent a reintervention to treat a type ia endoleak from the gore® excluder® aaa endoprosthesis featuring c3® delivery system.A gore® excluder® aaa endoprosthesis was implanted.The endoleak was stopped, and the patient tolerated the procedure.It was stated that the endoleak was likely caused by disease progression and calcification of the aorta.
|